{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:22:49Z","timestamp":1770967369057,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We need easy-to-use, valid biomarkers for diagnosing Alzheimer\u2019s disease (AD). Blood biomarkers are a promising option, especially as there is a good correlation with beta-amyloid and tau biomarkers measured by positron emission tomography or in the cerebrospinal fluid. We investigated the added value of measuring these markers in the blood of patients who have already been diagnosed, and how cut-off values can be set in clinical routine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma pTau 181 and pTau 217 levels were analyzed using Lumipulse G600II in 132 memory clinic outpatients with different forms of dementia and in 43 cognitively intact controls (CIC). Linear discriminant analysis was used to determine the diagnostic accuracy of pTau 181, pTau 217, and the pTau 217\/181 ratio in plasma. The Youden index (YI) was calculated to determine optimal cut-points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The diagnostic performance of pTau levels to distinguish between dementia patients and CIC yielded an AUC of 0.724 (95% CI: 0.635\u20130.813) with a cut point (YI) of 1.46 pg\/mL for pTau 181 and an AUC of 0.845 (95% CI: 0.763\u20130.927) with a cut point (YI) of 0.23 pg\/mL for pTau 217. The pTau217\/181 ratio showed slightly better discriminatory performance (AUC of 0.858 [95% CI: 0.769\u20130.946]) at a cut point (YI) of 0.18.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We suggest that the combined use of pTau217 and pTau181 as a ratio may serve as a valuable method to differentiate AD from non-AD dementia and from cognitively healthy individuals. However, plasma pTau217 outperforms pTau181 and the ratio due to its greater stability and marginally higher sensitivity compared to the 217\/181 ratio. Plasma pTau217 levels above the cut-off point could indicate the need for further investigation of biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1714247","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:37:52Z","timestamp":1770964672000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma phospho-tau 217 outperforms plasma phospho-tau 181 analyzed with Lumipulse in detecting Alzheimer\u2019s dementia in a real-world memory clinic population"],"prefix":"10.3389","volume":"18","author":[{"given":"Michaela","family":"Defrancesco","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry I, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke R.","family":"Gizewski","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University of Innsbruck","place":["Innsbruck, Austria"]},{"name":"Neuroimaging Core Facility, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Steiger","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University of Innsbruck","place":["Innsbruck, Austria"]},{"name":"Neuroimaging Core Facility, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Virgolini","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kroiss","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Schurr","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry I, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Paul","family":"G\u00f6rtz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy A, Hall State Hospital","place":["Hall in Tirol, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Marksteiner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy A, Hall State Hospital","place":["Hall in Tirol, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Hofer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry I, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Humpel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry I, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13195-024-01513-9","article-title":"Diagnostic performance of plasma pTau(217), pTau(181), Abeta(1-42) and Abeta(1-40) in the LUMIPULSE automated platform for the detection of Alzheimer disease.","volume":"16","author":"Arranz","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring.","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"105345","DOI":"10.1016\/j.ebiom.2024.105345","article-title":"Clinical value of plasma pTau181 to predict Alzheimer\u2019s disease pathology in a large real-world cohort of a memory clinic.","volume":"108","author":"Cano","year":"2024","journal-title":"EBioMedicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1007\/s00415-024-12631-7","article-title":"Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer\u2019s disease: A real-world study.","volume":"271","author":"Cecchetti","year":"2024","journal-title":"J. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1212\/wnl.48.5_suppl_6.10s","article-title":"The neuropsychiatric inventory: Assessing psychopathology in dementia patients.","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging.","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e12545","DOI":"10.1002\/dad2.12545","article-title":"Performance of the Lumipulse plasma A\u03b242\/40 and pTau181 immunoassays in the detection of amyloid pathology.","volume":"16","author":"Figdore","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3233\/AIC-170729","article-title":"Linear discriminant analysis: A detailed tutorial.","volume":"30","author":"Gaber","year":"2017","journal-title":"AI Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants.","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3233\/JAD-151111","article-title":"Differential diagnosis of dementia with high levels of cerebrospinal fluid tau protein.","volume":"51","author":"Grangeon","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials.","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","article-title":"Identifying and validating biomarkers for Alzheimer\u2019s disease.","volume":"29","author":"Humpel","year":"2011","journal-title":"Trends Biotechnol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup.","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease.","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e14458","DOI":"10.1002\/alz.14458","article-title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer\u2019s disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis.","volume":"21","author":"Khalafi","year":"2025","journal-title":"Alzheimers Dement."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/jnnp-2024-333467","article-title":"Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment.","volume":"95","author":"Lehmann","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.tjpad.2025.100264","article-title":"A modelling approach to derive population-specific cutoff for plasma p-Tau217.","volume":"12","author":"Liew","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"102290","DOI":"10.1016\/j.arr.2024.102290","article-title":"A critical appraisal of blood-based biomarkers for Alzheimer\u2019s disease.","volume":"96","author":"Lista","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1014305","DOI":"10.3389\/fnagi.2022.1014305","article-title":"Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer\u2019s disease.","volume":"14","author":"Marksteiner","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.14283\/jpad.2024.152","article-title":"Diagnostic accuracy of Plasma p-tau217 for detecting pathological cerebrospinal fluid changes in cognitively unimpaired subjects using the lumipulse platform.","volume":"11","author":"Mart\u00ednez-Dubarbie","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community.","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1038\/s41591-022-01822-2","article-title":"Author correction: Performance of plasma phosphorylated tau 181 and 217 in the community.","volume":"29","author":"Mielke","year":"2023","journal-title":"Nat. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","article-title":"Prediction of future Alzheimer\u2019s disease dementia using plasma phospho-tau combined with other accessible measures.","volume":"27","author":"Palmqvist","year":"2021","journal-title":"Nat. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","article-title":"Plasma phospho-tau217 for Alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform.","volume":"31","author":"Palmqvist","year":"2025","journal-title":"Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WAD.0b013e31815c3445","article-title":"Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): Current limitations and future directions.","volume":"21","author":"Rascovsky","year":"2007","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B28","volume-title":"Statistics in Medicine","author":"Riffenburgh","year":"2012"},{"key":"B29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: An open-source package for R and S+ to analyze and compare ROC curves.","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinform."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease.","volume":"141","author":"Rosen","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF00868807","article-title":"Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability.","volume":"242","author":"Scheltens","year":"1995","journal-title":"J. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d; Alzheimer\u2019s disease and normal ageing: Diagnostic value and neuropsychological correlates.","volume":"55","author":"Scheltens","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jalz.2016.10.007","article-title":"The vascular impairment of cognition classification consensus study.","volume":"13","author":"Skrobot","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: Towards clinical implementation.","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: A retrospective diagnostic performance study.","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/alz.70038","article-title":"Diagnostic accuracy of plasma p-tau217\/Abeta42 for Alzheimer\u2019s disease in clinical and community cohorts.","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement."},{"key":"B38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: A preliminary report.","volume":"17","author":"Yesavage","year":"1982","journal-title":"J. Psychiatr. Res."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1714247\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:37:55Z","timestamp":1770964675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1714247\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":38,"alternative-id":["10.3389\/fnagi.2026.1714247"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1714247","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"article-number":"1714247"}}